As a global leader in clinical oncology services, we deliver the latest evidence-based treatments in safe and high-quality environments across a number of specialties.
We believe care should be available when and where patients need it most and it should be designed to give patients the best outcomes possible.
At our 14 oncology outpatient centres throughout the UK, we provide specialist cancer services with the latest technologies and leading consultants, treating all adult cancers and specialising in breast, prostate, head and neck, haematology and neuro-oncology.
We are a centre of excellence for stereotactic radiosurgery (SRS) for private patients across the UK, delivered through a team of leading clinicians at our centres in London and Oxford. We have also established a stereotactic ablative radiotherapy (SABR) network led by a team of leading SABR experts that offers world-class techniques. Our advanced technologies include sophisticated imaging and motion monitoring and MRIdian MR-guided radiotherapy for real-time adaptive planning and delivery.
Governance and safety
A focus on clinical excellence
Through regulation and governance, we deliver the latest evidence-based treatments, ensuring patients receive the best possible care, safely and without delay. Our dedicated multidisciplinary teams comprise of experienced clinicians who provide the necessary clinical oversight for safe and effective care across our network.